HGH Fragment 176-191.
It is a 16-amino-acid piece of the growth hormone sequence, supplied as a research peptide. What it does in people has not been measured, so there is no established effect to describe.
Reviewed March 2026
- Category
- Peptide
What HGH Fragment 176-191 is, and what it does.
- Does it work
- This suits laboratory research rather than a daily routine, since one published record exists and no human outcome has been recorded for it.
- How much to take
- The band on record is 250mcg to 500mcg a day, and the 1,000mcg figure is a research condition. No amount has been established for people outside research.
- Time to feel it
- Nobody has measured this in people. With one record in the published literature, there is no onset figure anyone can stand behind.
- The first dose
- Nothing has been documented for day one in people. With one record in the literature, there is no first-day account anyone can stand behind.
- With regular use
- What weeks of daily use do has not been studied in humans. That is a gap in the literature rather than a finding either way.
- How well tolerated
- Human safety has not been characterised, and a single published record cannot support a profile. Speak to a doctor before considering anything in this category.
- How it feels
- No subjective experience has been documented under controlled conditions, so there is nothing on record to describe here.
- The overlooked benefit
- Swallowed, a peptide this short is cut apart by stomach and gut enzymes before it reaches the blood, so an oral form does not deliver the intact fragment.
250 to 500mcg a day is where HGH Fragment 176-191 works.
Source: Ng et al., Horm Res, 2000 (limited preclinical data)
The proof, claim by claim.
These words describe the research, not the molecule's worth. Research strength is how much work stands behind one claim, and it is never a product score.
HGH Fragment 176-191 has emerging evidence. Based on 1+ studies.
- Fat metabolism in animal modelsAnimal study
- Lipolytic activity in isolated fat cellsIn vitro study
- Growth hormone receptor activation by a 16-residue fragmentNarrative review
Questions people ask about HGH Fragment 176-191.
- When should I take it?
- Timing matters less than consistency. Pick a time that works for you and take it daily.
- Can I take it with other supplements?
- Usually fine. The main thing to watch is not doubling up on the same ingredient from different products. If you're on prescription meds, check with your pharmacist first.
- Any side effects to watch for?
- Most people tolerate it well at recommended doses. GI upset is the most common complaint with any supplement. Start with a lower dose and work up. If something feels off, stop and reassess.
- Who benefits most from this?
- Honestly, most people would benefit more from the basics. But if you've got a specific reason to try it, the risk is generally low.
No pairing data for HGH Fragment 176-191 yet.
Nothing on file for HGH Fragment 176-191, either from a combination trial or from settled biochemistry. When either lands, it appears here with its source.
Stitching two separate single-ingredient studies into a pairing is the one thing this engine will not do. When a study of the combination itself holds up at source, it lands here with its citation.
No invented synergy. Where actives were studied on their own rather than together, the record shows each on its own evidence, never a combined effect no trial measured.
Research strength. Research strength says how much work stands behind the combination. It is never a product score.
Independent record. Every finding is cited to a named trial, dated, and never written by the brand.
21 pairings are live across the library today. Checked 9 August 2026.
Nothing specific on file for HGH Fragment 176-191. Match the label to the daily amount above, and tell your doctor what you take.
Not medical advice. Show the label to your pharmacist.What HGH Fragment 176-191 actually does.
Fragment 176-191 is a synthetic peptide corresponding to the carboxy-terminal residues 176 to 191 of the 191-amino-acid human growth hormone sequence. It is a defined 16-residue fragment, not a modified whole hormone.
Peptides of this length are cleaved by gastric pepsin and by pancreatic and brush-border peptidases, so an orally swallowed peptide of this size is hydrolysed to shorter fragments and amino acids before it can reach circulation intact.
Short synthetic peptides are typically supplied as acetate or trifluoroacetate salts of the lyophilised material, and the counter-ion, residual solvent and water content all sit inside the declared weight, which is why net peptide content differs from gross powder weight.
Growth hormone signalling requires the intact hormone to bind and dimerise two growth hormone receptors, a function distributed across binding surfaces on the folded full-length protein. A 16-residue linear fragment does not carry those complete binding surfaces.
Getting HGH Fragment 176-191 from food.
The whole-food sources on file. A supplement closes the gap, it does not replace dinner.
A gram-for-gram figure (how much of each you would eat to match a dose) will appear here once it is sourced and reviewed. This page will not print a number it cannot cite.
The forms it comes in.
The essence, in one line each.
- A methods review of chemoenzymatic semisynthesis, describing how enzymes and chemical ligation are combined to assemble defined peptide and protein sequences; it grounds how a short defined-sequence peptide is made and reports nothing about any effect of this fragment.Narrative review. Thompson RE et al., 2020 (Chemical Reviews). PMID 31774265 ↗
These are the studies our verdict leans on, chosen from the 1 we read for HGH Fragment 176-191. The full linked list is below.
FDA Disclaimer: These statements have not been evaluated by the Food and Drug Administration. This information is for educational purposes only and is not intended to diagnose, treat, cure, or prevent any disease. Consult your healthcare provider before starting any supplement regimen.